Literature DB >> 27553358

Crosstalk in skin: melanocytes, keratinocytes, stem cells, and melanoma.

Joshua X Wang1, Mizuho Fukunaga-Kalabis1, Meenhard Herlyn2.   

Abstract

In the vertebrate embryo, melanocytes arise from the neural crest, migrate to and colonize the basal layer within the skin and skin appendages. Post-migratory melanocytes are securely attached to the basement membrane, and their morphology, growth, adhesion, and migration are under control of neighboring keratinocytes. Melanoma is a malignant tumor originated from melanocytes or their progenitor cells. During melanocyte transformation and melanoma progression, melanocytes lose their interactions with keratinocytes, resulting in uncontrolled proliferation and invasion of the malignant cells. Melanoma cells at the advanced stages often lack melanocytic features and resemble multipotent progenitors, which are a potential melanocyte reservoir in human skin. In this mini-review, we will summarize findings on cell-cell interactions that are responsible for normal melanocyte homeostasis, stem cell self-renewal, and differentiation. Our ultimate goal is to define molecules and pathways, which are essential for normal cell-cell interactions but deregulated in melanoma formation and progression.

Entities:  

Keywords:  Cell-cell interaction; Keratiocyte; Melanocyte; Melanoma; Stem cell

Year:  2016        PMID: 27553358      PMCID: PMC5055506          DOI: 10.1007/s12079-016-0349-3

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  46 in total

1.  A dermal niche for multipotent adult skin-derived precursor cells.

Authors:  Karl J L Fernandes; Ian A McKenzie; Pleasantine Mill; Kristen M Smith; Mahnaz Akhavan; Fanie Barnabé-Heider; Jeff Biernaskie; Adrienne Junek; Nao R Kobayashi; Jean G Toma; David R Kaplan; Patricia A Labosky; Victor Rafuse; Chi-Chung Hui; Freda D Miller
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

Review 2.  Signal transduction in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Pigment Cell Res       Date:  1994-04

3.  Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.

Authors:  Anne Sophie Ricard; Catherine Pain; Alexia Daubos; Khaled Ezzedine; Isabelle Lamrissi-Garcia; Alice Bibeyran; Veronique Guyonnet-Dupérat; Alain Taieb; Muriel Cario-André
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

4.  Isolation of multipotent adult stem cells from the dermis of mammalian skin.

Authors:  J G Toma; M Akhavan; K J Fernandes; F Barnabé-Heider; A Sadikot; D R Kaplan; F D Miller
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

5.  Dominant role of the niche in melanocyte stem-cell fate determination.

Authors:  Emi K Nishimura; Siobhán A Jordan; Hideo Oshima; Hisahiro Yoshida; Masatake Osawa; Mariko Moriyama; Ian J Jackson; Yann Barrandon; Yoshiki Miyachi; Shin-Ichi Nishikawa
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

6.  Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.

Authors:  Caroline Robert; Antoni Ribas; Jedd D Wolchok; F Stephen Hodi; Omid Hamid; Richard Kefford; Jeffrey S Weber; Anthony M Joshua; Wen-Jen Hwu; Tara C Gangadhar; Amita Patnaik; Roxana Dronca; Hassane Zarour; Richard W Joseph; Peter Boasberg; Bartosz Chmielowski; Christine Mateus; Michael A Postow; Kevin Gergich; Jeroen Elassaiss-Schaap; Xiaoyun Nicole Li; Robert Iannone; Scot W Ebbinghaus; S Peter Kang; Adil Daud
Journal:  Lancet       Date:  2014-07-15       Impact factor: 79.321

7.  Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin.

Authors:  A Reichert-Faria; J E Jung; V Moreschi Neto; C C Silva de Castro; M T Mira; L Noronha
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-27       Impact factor: 6.166

8.  Phase I/II study of ipilimumab for patients with metastatic melanoma.

Authors:  Jeffrey S Weber; Steven O'Day; Walter Urba; John Powderly; Geoff Nichol; Michael Yellin; Jolie Snively; Evan Hersh
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

9.  COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

Authors:  Cory M Johannessen; Jesse S Boehm; So Young Kim; Sapana R Thomas; Leslie Wardwell; Laura A Johnson; Caroline M Emery; Nicolas Stransky; Alexandria P Cogdill; Jordi Barretina; Giordano Caponigro; Haley Hieronymus; Ryan R Murray; Kourosh Salehi-Ashtiani; David E Hill; Marc Vidal; Jean J Zhao; Xiaoping Yang; Ozan Alkan; Sungjoon Kim; Jennifer L Harris; Christopher J Wilson; Vic E Myer; Peter M Finan; David E Root; Thomas M Roberts; Todd Golub; Keith T Flaherty; Reinhard Dummer; Barbara L Weber; William R Sellers; Robert Schlegel; Jennifer A Wargo; William C Hahn; Levi A Garraway
Journal:  Nature       Date:  2010-11-24       Impact factor: 49.962

10.  Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Authors:  M Fukunaga-Kalabis; G Martinez; S M Telson; Z-J Liu; K Balint; I Juhasz; D E Elder; B Perbal; M Herlyn
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 8.756

View more
  21 in total

Review 1.  Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.

Authors:  Chi-Ping Day; Rachel Marchalik; Glenn Merlino; Helen Michael
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

2.  Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes.

Authors:  Njainday Pulo Jobe; Veronika Živicová; Alžběta Mifková; Daniel Rösel; Barbora Dvořánková; Ondřej Kodet; Hynek Strnad; Michal Kolář; Aleksi Šedo; Karel Smetana; Karolina Strnadová; Jan Brábek; Lukáš Lacina
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

Review 3.  Next generation human skin constructs as advanced tools for drug development.

Authors:  H E Abaci; Zongyou Guo; Yanne Doucet; Joanna Jacków; Angela Christiano
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-07

4.  Melanin concentration maps by label-free super-resolution photo-thermal imaging on melanoma biopsies.

Authors:  Margaux Bouzin; Mario Marini; Giuseppe Chirico; Francesca Granucci; Francesca Mingozzi; Roberto Colombo; Laura D'Alfonso; Laura Sironi; Maddalena Collini
Journal:  Biomed Opt Express       Date:  2022-02-03       Impact factor: 3.732

5.  Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation.

Authors:  Brandon M Murphy; Elizabeth M Terrell; Venkat R Chirasani; Tirzah J Weiss; Rachel E Lew; Andrea M Holderbaum; Aastha Dhakal; Valentina Posada; Marie Fort; Michael S Bodnar; Leiah M Carey; Min Chen; Craig J Burd; Vincenzo Coppola; Deborah K Morrison; Sharon L Campbell; Christin E Burd
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 6.  Advances in Carbon Nanotubes for Malignant Melanoma: A Chance for Treatment.

Authors:  Elidamar Nunes de Carvalho Lima; José Roberto Castilho Piqueira; Durvanei Augusto Maria
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

7.  Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging.

Authors:  Gerald Saldanha; Jeremy Yarrow; Jay Pancholi; Katarina Flatman; Kah Wee Teo; Somaia Elsheik; Rebecca Harrison; Marie O'Riordan; Mark Bamford
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

8.  Microfluidic model with air-walls reveals fibroblasts and keratinocytes modulate melanoma cell phenotype, migration, and metabolism.

Authors:  Jose M Ayuso; Shreyans Sadangi; Marcos Lares; Shujah Rehman; Mouhita Humayun; Kathryn M Denecke; Melissa C Skala; David J Beebe; Vijayasaradhi Setaluri
Journal:  Lab Chip       Date:  2021-02-03       Impact factor: 6.799

9.  LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance.

Authors:  Ola Billing; Ylva Holmgren; Daniel Nosek; Håkan Hedman; Oskar Hemmingsson
Journal:  Oncogene       Date:  2021-05-04       Impact factor: 9.867

10.  The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease.

Authors:  Ildefonso Rodriguez-Leyva; Erika Chi-Ahumada; Manuel Mejía; Juan P Castanedo-Cazares; William Eng; Sami K Saikaly; Juan Carrizales; Todd D Levine; Robert A Norman; Maria E Jimenez-Capdeville
Journal:  Mov Disord Clin Pract       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.